Publications by authors named "Fabian C Franke"

Interleukin 12 (IL-12) family cytokines are secreted proteins that regulate immune responses. Each family member is a heterodimer and nature uses shared building blocks to assemble the functionally distinct IL-12 cytokines. In recent years we have gained insights into the molecular principles and cellular regulation of IL-12 family biogenesis.

View Article and Find Full Text PDF

Intracellular adaptor proteins are indispensable for the transduction of receptor-derived signals, as they recruit and connect essential downstream effectors. The SLy/SASH1-adaptor family comprises three highly homologous proteins, all of them sharing conserved structural motifs. The initial characterization of the first member SLy1/SASH3 (SH3 protein expressed in lymphocytes 1) in 2001 was rapidly followed by identification of SLy2/HACS1 (hematopoietic adaptor containing SH3 and SAM domains 1) and SASH1/SLy3 (SAM and SH3 domain containing 1).

View Article and Find Full Text PDF

Epithelial-mesenchymal transition (EMT) is a cell plasticity process required for metastasis and chemoresistance of carcinoma cells. We report a crucial role of the signal adaptor proteins CRK and CRKL in promoting EMT and tumor aggressiveness, as well as resistance against chemotherapy in colorectal and pancreatic carcinoma. Genetic loss of either CRKL or CRK partially counteracted EMT in three independent cancer cell lines.

View Article and Find Full Text PDF
Article Synopsis
  • SASH1 is a tumor-suppressor gene that plays a crucial role in preventing metastasis in colorectal cancer, particularly with its loss linked to the spread of the disease.
  • The study involved manipulating SASH1 levels in colon cancer cells using advanced genetic techniques, enabling researchers to observe changes in cell behavior related to metastasis and resistance to chemotherapy.
  • Results indicated that lower SASH1 levels promote a process called epithelial-mesenchymal transition (EMT), leading to more invasive cancer traits, while SASH1 interacts with the oncoprotein CRKL to inhibit pathways necessary for EMT, reducing the potential for metastasis.
View Article and Find Full Text PDF